Delivery Order SPE2DB25D3306-SPE2DB25FUCCB
Award Date 7/1/25
Potential Completion Date 7/2/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Estrace 0.01% Cream, a pharmaceutical product, with a ceiling value of $1,331.41 and a completion date of March 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, to provide Estrace 0.01% cream. The contract is a firm fixed price delivery order with a ceiling value of $1,736.50 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp. is the prime contractor for this award, which does not have a set-aside designation. The contract is a part of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,315.53 firm fixed price delivery order is for the pharmaceutical product Estrace 0.01% Cream, 42.5 gm. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. This delivery order is associated with a larger $999,999,999 Indefinite Delivery...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,268.29 firm fixed price order is for the supply of ESTRACE 0.01% Cream 42.5GM, a prescription pharmaceutical product. Amerisourcebergen, a major pharmaceutical distributor, holds multiple federal contracts and IDCs to provide a wide range of medical commodities, including prescription...
- This federal contract award, with ID SPE2DB24D2101|SPE2DB25FKJSG, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.24 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, 42.5 gm. This order is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order (SPE2DB22D1017|SPE2DB24FF3AK) with a ceiling value of $2,415.00 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estrace 0.01% cream, a prescription medication, to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,312.14 for the pharmaceutical product Estrace 0.01% Cream 42.5GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, on September 14, 2021, with a completion date of September 15, 2021. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competed on an unrestricted basis. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Estrace 0.01% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,513.26, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 2, 2023. The contract has a completion date of June 5, 2023 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds...
- This $2,048.36 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of Estrace 0.01% Cream, a prescription pharmaceutical product, to support the medical needs of U.S. government agencies and healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,169.91 Firm Fixed Price delivery order is for the supply of Estrace 0.01% cream, a topical estrogen product, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...